Biotransformation of the immunomodulator, 3-(p-chlorophenyl)-2,3-dihydro-3-hydroxythiazolo[3,2a]benzimidazole-2-acetic acid, and its relationship to thyroid toxicity.
D000276:Adjuvants, Immunologic / Q000378:metabolism* / Q000633:toxicity; D000818:Animals; D001562:Benzimidazoles / Q000378:metabolism* / Q000633:toxicity; D001711:Biotransformation; D004285:Dogs; D008099:Liver / Q000378:metabolism; D051381:Rats; D013045:Species Specificity; D013844:Thiazoles / Q000378:metabolism / Q000633:toxicity; D013959:Thyroid Diseases / Q000139:chemically induced*; D013961:Thyroid Gland / Q000378:metabolism; D013974:Thyroxine / Q000494:pharmacology; D014018:Tissue Distribution
D000276:Adjuvants, Immunologic; D001562:Benzimidazoles; D013844:Thiazoles; C012139:Wy 13876; D013974:Thyroxine